Serum 25-hydroxy-vitamin D3 concentrations increase during tuberculosis treatment in Tanzania

International Journal of Tuberculosis and Lung Disease

Volumn 14, Issue 9, 2010, Pages 1147-1152

  Tostmann, Alma ^a   Wielders, J P M ^b   Kibiki, G S ^c   Verhoef, H ^d   Boeree, M J ^a   Van Der Ven, A J A M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MEANDER MEDICAL CENTER   (Netherlands)

^c KILIMANJARO CHRISTIAN MEDICAL CENTRE   (Tanzania)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Anti tuberculosis treatment; Isoniazid; Mycobacterium tuberculosis; Nutrition; Rifampicin

Indexed keywords

ALBUMIN; CALCIFEDIOL; CALCIUM; ETHAMBUTOL; ISONIAZID; MAGNESIUM; PARATHYROID HORMONE; PHOSPHATE; PYRAZINAMIDE; RIFAMPICIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CORRELATION ANALYSIS; DRUG EFFECT; DRUG METABOLISM; FEMALE; HOSPITAL PATIENT; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; SPUTUM ANALYSIS; TANZANIA; TREATMENT DURATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM;

ADULT; ANTITUBERCULAR AGENTS; CALCIFEDIOL; FEMALE; HOSPITALIZATION; HUMANS; ISONIAZID; MALE; PARATHYROID HORMONE; RIFAMPIN; SUNLIGHT; TANZANIA; TUBERCULOSIS, PULMONARY; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 77956566529     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Martineau A R, Honecker F U, Wilkinson R J, Griffiths C J. Vitamin D in the treatment of pulmonary tuberculosis. J Steroid Biochem Mol Biol 2007; 103: 793-798.
2. Zasloff M. Fighting infections with vitamin D. Nat Med 2006; 12: 388-390.
3. Gibney K B, MacGregor L, Leder K, et al. Vitamin D deficiency is associated with tuberculosis and latent tuberculosis infection in immigrants from sub-Saharan Africa. Clin Infect Dis 2008; 46: 443-446. (Pubitemid 351263529)
4. Wejse C, Olesen R, Rabna P, et al. Serum 25-hydroxyvitamin D in a West African population of tuberculosis patients and unmatched healthy controls. Am J Clin Nutr 2007; 86: 1376-1383. (Pubitemid 350126241)
5. Babb C, van der Merwe L, Beyers N, et al. Vitamin D receptor gene polymorphisms and sputum conversion time in pulmonary tuberculosis patients. Tuberculosis (Edinb) 2007; 87: 295-302. (Pubitemid 46951033)
6. Roth D E, Soto G, Arenas F, et al. Association between vitamin D receptor gene polymorphisms and response to treatment of pulmonary tuberculosis. J Infect Dis 2004; 190: 920-927. (Pubitemid 39120969)
7. Bengoa J M, Bolt M J, Rosenberg I H. Hepatic vitamin D 25-hydroxylase inhibition by cimetidine and isoniazid. J Lab Clin Med 1984; 104: 546-552. (Pubitemid 14015750)
8. Gupta R P, He Y A, Patrick K S, Halpert J R, Bell N H. CYP3A4 is a vitamin D-24- and 25-hydroxylase: analysis of structure function by site-directed mutagenesis. J Clin Endocrinol Metab 2005; 90: 1210-1219.
9. Desta Z, Soukhova N V, Flockhart D A. Inhibition of cytochrome P450 (CYP450) isoforms by isoniazid: potent inhibition of CYP2C19 and CYP3A. Antimicrob Agents Chemother 2001; 45: 382-392. (Pubitemid 32105271)
10. Rook G A, Steele J, Fraher L, et al. Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology 1986; 57: 159-163.
11. 3 of the multiplication of virulent tubercle bacilli in cultured human macrophages. Infect Immun 1987; 55: 2945-2950.
12. Adams J S, Ren S Y. Autoregulation of 1,25-dihydroxyvitamin D synthesis in macrophage mitochondria by nitric oxide. Endocrinology 1996; 137: 4514-4517. (Pubitemid 26321905)
13. Brodie M J, Boobis A R, Hillyard C J, Abeyasekera G, MacIntyre I, Park B K. Effect of isoniazid on vitamin D metabolism and hepatic monooxygenase activity. Clin Pharmacol Ther 1981; 30: 363-367.
14. Brodie M J, Boobis A R, Hillyard C J, et al. Effect of rifampicin and isoniazid on vitamin D metabolism. Clin Pharmacol Ther 1982; 32: 525-530. (Pubitemid 13096730)
15. Goodwin B, Hodgson E, Liddle C. The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module. Mol Pharmacol 1999; 56: 1329-1339.
16. Brodie M J, Boobis A R, Dollery C T, et al. Rifampicin and vitamin D metabolism. Clin Pharmacol Ther 1980; 27: 810-814.
17. Wejse C, Gomes V F, Rabna P, et al. Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med 2009; 179: 843-850.
18. Martineau A R, Nanzer A M, Satkunam K R, et al. Influence of a single oral dose of vitamin D(2) on serum 25-hydroxy-vitamin D concentrations in tuberculosis patients. Int J Tuberc Lung Dis 2009; 13: 119-125.
19. Villamor E. A potential role for vitamin D on HIV infection? Nutr Rev 2006; 64: 226-233.
20. World Health Organization. Global tuberculosis control 2009: surveillance, planning, financing. WHO report 2009. WHO/HTM/TB/2009.411. Geneva, Switzerland: WHO, 2009.
21. Vieth R. What is the optimal vitamin D status for health? Prog Biophys Mol Biol 2006; 92: 26-32.
22. Salaniponi F M, Christensen J J, Gausi F, Kwanjana J J, Harries A D. Sputum smear status at two months and subsequent treatment outcome in new patients with smear-positive pulmonary tuberculosis. Int J Tuberc Lung Dis 1999; 3: 1047-1048.
23. Holick M F. Vitamin D deficiency. N Engl J Med 2007; 357: 266-281.
24. Cavalier E, Delanaye P, Chapelle J P, Souberbielle J C. Vitamin D: current status and perspectives. Clin Chem Lab Med 2009; 47: 120-127.
25. Stoffels K, Overbergh L, Giulietti A, Verlinden L, Bouillon R, Mathieu C. Immune regulation of 25-hydroxyvitamin-D3-1 alpha-hydroxylase in human monocytes. J Bone Miner Res 2006; 21: 37-47. (Pubitemid 43023225)
26. Overbergh L, Stoffels K, Waer M, Verstuyf A, Bouillon R, Mathieu C. Immune regulation of 25-hydroxyvitamin D-1 a lpha-hydroxylase in human monocytic THP1 cells: mechanisms of interferon-gamma-mediated induction. J Clin Endocrinol Metab 2006; 91: 3566-3574. (Pubitemid 44402139)
27. Friis H, Range N, Pedersen M L, et al. Hypovitaminosis D is common among pulmonary tuberculosis patients in Tanzania but is not explained by the acute phase response. J Nutr 2008; 138: 2474-2480.